⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for myxofibrosarcoma

Every month we try and update this database with for myxofibrosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaNCT04996004
Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallNCT03651375
Sarcoma
Fibrosarcoma
Leiomyosarcoma
Liposarcoma
Myosarcoma
Histiocytic Sar...
Synovial Sarcom...
Lymphangiosarco...
Malignant Perip...
Myxofibrosarcom...
Myxoid Liposarc...
Undifferentiate...
Pleomorphic Lip...
Undifferentiate...
Dedifferentiate...
Pleomorphic Rha...
Malignant Trito...
Sequential chem...
Hypofractionate...
18 Years - 100 YearsMaria Sklodowska-Curie National Research Institute of Oncology
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaNCT04996004
Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasNCT04906876
Sarcoma
Soft Tissue Sar...
Metastatic Sarc...
Undifferentiate...
Myxofibrosarcom...
Leiomyosarcoma
Liposarcoma
Angiosarcoma
Synovial Sarcom...
Rhabdomyosarcom...
Spindle Cell Sa...
High Grade Sarc...
Bone Sarcoma
Gemcitabine
Docetaxel
9-ING-41
10 Years - Brown University
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryNCT02180867
Alveolar Soft P...
Angiomatoid Fib...
Atypical Fibrox...
Clear Cell Sarc...
Epithelioid Mal...
Epithelioid Sar...
Extraskeletal M...
Extraskeletal O...
Fibrohistiocyti...
Fibrosarcoma
Inflammatory My...
Intimal Sarcoma
Leiomyosarcoma
Liposarcoma
Liver Embryonal...
Low Grade Fibro...
Low Grade Myofi...
Malignant Cutan...
Malignant Perip...
Malignant Trito...
Mesenchymal Cho...
Myxofibrosarcom...
Myxoid Chondros...
Myxoinflammator...
Nerve Sheath Ne...
PEComa
Pericytic Neopl...
Plexiform Fibro...
Sclerosing Epit...
Skin Glomus Tum...
Stage IB Soft T...
Stage IIB Soft ...
Stage III Soft ...
Stage IV Soft T...
Synovial Sarcom...
Undifferentiate...
Doxorubicin
Doxorubicin Hyd...
Ifosfamide
Pazopanib
Pazopanib Hydro...
Radiation Thera...
Therapeutic Con...
2 Years - National Cancer Institute (NCI)
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryNCT02180867
Alveolar Soft P...
Angiomatoid Fib...
Atypical Fibrox...
Clear Cell Sarc...
Epithelioid Mal...
Epithelioid Sar...
Extraskeletal M...
Extraskeletal O...
Fibrohistiocyti...
Fibrosarcoma
Inflammatory My...
Intimal Sarcoma
Leiomyosarcoma
Liposarcoma
Liver Embryonal...
Low Grade Fibro...
Low Grade Myofi...
Malignant Cutan...
Malignant Perip...
Malignant Trito...
Mesenchymal Cho...
Myxofibrosarcom...
Myxoid Chondros...
Myxoinflammator...
Nerve Sheath Ne...
PEComa
Pericytic Neopl...
Plexiform Fibro...
Sclerosing Epit...
Skin Glomus Tum...
Stage IB Soft T...
Stage IIB Soft ...
Stage III Soft ...
Stage IV Soft T...
Synovial Sarcom...
Undifferentiate...
Doxorubicin
Doxorubicin Hyd...
Ifosfamide
Pazopanib
Pazopanib Hydro...
Radiation Thera...
Therapeutic Con...
2 Years - National Cancer Institute (NCI)
Phase 2 Study of 9-ING-41 With Chemotherapy in SarcomaNCT05116800
Soft Tissue Sar...
Undifferentiate...
Myxofibrosarcom...
Leiomyosarcoma
Liposarcoma
Angiosarcoma
Synovial Sarcom...
Rhabdomyosarcom...
Spindle Cell Sa...
High Grade Sarc...
Bone Sarcoma
Osteosarcoma
Ewing Sarcoma o...
Gemcitabine
9-ING-41
Docetaxel
10 Years - Brown University
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic SarcomaNCT02601209
High Grade Sarc...
Metastatic Leio...
Metastatic Mali...
Metastatic Syno...
Metastatic Undi...
Metastatic Unre...
Myxofibrosarcom...
Recurrent Leiom...
Recurrent Malig...
Recurrent Synov...
Recurrent Undif...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Unresectable Le...
Pazopanib
Pazopanib Hydro...
Sapanisertib
18 Years - National Cancer Institute (NCI)
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaNCT04420975
Leiomyosarcoma
Malignant Perip...
Myxofibrosarcom...
Pleomorphic Rha...
Resectable Dedi...
Resectable Soft...
Resectable Undi...
Soft Tissue Fib...
Spindle Cell Sa...
Stage I Retrope...
Stage I Soft Ti...
Stage IA Retrop...
Stage IA Soft T...
Stage IB Retrop...
Stage IB Soft T...
Stage II Retrop...
Stage II Soft T...
Stage III Retro...
Stage III Soft ...
Stage IIIA Retr...
Stage IIIA Soft...
Stage IIIB Retr...
Stage IIIB Soft...
Storiform-Pleom...
Synovial Sarcom...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Undifferentiate...
Definitive Surg...
Nanoplexed Poly...
Nivolumab
Radiation Thera...
18 Years - Jonsson Comprehensive Cancer Center
Alisertib in Treating Patients With Advanced or Metastatic SarcomaNCT01653028
Myxofibrosarcom...
Recurrent Adult...
Recurrent Leiom...
Recurrent Lipos...
Recurrent Malig...
Recurrent Undif...
Stage III Soft ...
Stage IV Soft T...
Alisertib
Laboratory Biom...
18 Years - National Cancer Institute (NCI)
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryNCT03009201
Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue SarcomaNCT02584309
Sarcoma, Soft T...
Soft Tissue Sar...
Undifferentiate...
Leiomyosarcoma
Liposarcoma
Synovial Sarcom...
Myxofibrosarcom...
Angiosarcoma
Fibrosarcoma
Malignant Perip...
Epithelioid Sar...
Dexrazoxane
Doxorubicin
18 Years - Washington University School of Medicine
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryNCT03009201
Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute
ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or MyxofibrosarcomaNCT04480502
Undifferentiate...
Myxofibrosarcom...
Envafolimab
Ipilimumab
12 Years - Tracon Pharmaceuticals Inc.
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaNCT04996004
Leiomyosarcoma
Ontorpacept (TT...
Doxorubicin
18 Years - Pfizer
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegNCT04332874
Sarcoma
Myxofibrosarcom...
Undifferentiate...
Alveolar Soft P...
Isolated Limb I...
Pembrolizumab
infusion of mel...
12 Years - Memorial Sloan Kettering Cancer Center
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasNCT04242238
Sarcoma
Advanced Sarcom...
High Grade Sarc...
Leiomyosarcoma
Undifferentiate...
Myxofibrosarcom...
Dedifferentiate...
DCC-3014
Avelumab
18 Years - Memorial Sloan Kettering Cancer Center
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With SarcomaNCT03425279
Undifferentiate...
Myxofibrosarcom...
CAB-AXL-ADC
PD-1 inhibitor
12 Years - BioAtla, Inc.
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasNCT04242238
Sarcoma
Advanced Sarcom...
High Grade Sarc...
Leiomyosarcoma
Undifferentiate...
Myxofibrosarcom...
Dedifferentiate...
DCC-3014
Avelumab
18 Years - Memorial Sloan Kettering Cancer Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryNCT03009201
Advanced Soft T...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Metastatic Angi...
Metastatic Epit...
Metastatic Fibr...
Metastatic Lipo...
Metastatic Mali...
Metastatic Myxo...
Metastatic Soft...
Metastatic Syno...
Metastatic Undi...
Myxofibrosarcom...
Pleomorphic Rha...
Stage III Soft ...
Stage IV Soft T...
Undifferentiate...
Unresectable Le...
Unresectable Li...
Unresectable Ma...
Unresectable So...
Unresectable Sy...
Unresectable Un...
Doxorubicin Hyd...
Laboratory Biom...
Pharmacological...
Ribociclib
12 Years - OHSU Knight Cancer Institute
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallNCT03651375
Sarcoma
Fibrosarcoma
Leiomyosarcoma
Liposarcoma
Myosarcoma
Histiocytic Sar...
Synovial Sarcom...
Lymphangiosarco...
Malignant Perip...
Myxofibrosarcom...
Myxoid Liposarc...
Undifferentiate...
Pleomorphic Lip...
Undifferentiate...
Dedifferentiate...
Pleomorphic Rha...
Malignant Trito...
Sequential chem...
Hypofractionate...
18 Years - 100 YearsMaria Sklodowska-Curie National Research Institute of Oncology
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: